Nobel Award Honors Pioneering Body's Defenses Discoveries

The prestigious award in medical science has been granted for transformative findings that clarify how the body's defense network targets harmful pathogens while sparing the healthy tissues.

Three esteemed scientists—Japan's Prof. Sakaguchi and US scientists Mary Brunkow and Fred Ramsdell—share this accolade.

Their research identified unique "security guards" within the defense system that eliminate malfunctioning immune cells capable of harming the body.

The findings are now enabling innovative therapies for autoimmune diseases and cancer.

These winners will share a monetary award worth 11 million Swedish kronor.

Decisive Discoveries

"Their work has been essential for comprehending how the immune system operates and the reason we do not all suffer from serious autoimmune diseases," stated the head of the Nobel Committee.

This trio's studies address a fundamental mystery: In what way does the immune system defend us from numerous infections while keeping our own tissues intact?

Our body's protection system employs white blood cells that search for indicators of disease, even pathogens and bacteria it has not met before.

Such cells utilize sensors—called receptors—that are generated randomly in countless combinations.

That gives the immune system the capacity to combat a broad range of invaders, but the randomness of the mechanism unavoidably produces immune cells that may attack the body.

Security Guards of the Immune System

Scientists earlier understood that some of these harmful defense cells were eliminated in the immune organ—where immune cells develop.

The latest Nobel Prize recognizes the discovery of regulatory T-cells—described as the immune system's "peacekeepers"—which travel through the body to neutralize other defenders that attack the body's own tissues.

It is known that this mechanism malfunctions in autoimmune diseases such as type-1 diabetes, MS, and RA.

A Nobel panel added, "The findings have established a new field of investigation and accelerated the creation of innovative treatments, for example for tumors and autoimmune diseases."

Regarding malignancies, regulatory T-cells block the system from attacking the growth, so research are focused on reducing their numbers.

For autoimmune diseases, trials are exploring increasing regulatory T-cells so the body is no longer under attack. A comparable method could also be useful in minimizing the risks of transplanted organ rejection.

Pioneering Studies

Prof Sakaguchi, of a Japanese institution, conducted tests on rodents that had their immune gland extracted, causing autoimmune disease.

He showed that injecting defense cells from healthy animals could stop the illness—suggesting there was a mechanism for blocking defenders from attacking the host.

Mary Brunkow, affiliated with the a research center in a US city, and Fred Ramsdell, now at a biotech firm in a California city, were investigating an genetic immune disorder in mice and humans that resulted in the discovery of a genetic factor critical for the way T-regs operate.

"The pioneering research has uncovered how the immune system is kept in check by T-reg cells, preventing it from mistakenly attacking the healthy cells," said a leading biological science expert.

"The work is a striking example of how basic biological research can have far-reaching consequences for human health."